Inge van Rossum

Summary

Affiliation: Eli Lilly and Company

Country: USA

Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis
Inge van Rossum
Medical Department, Eli Lilly Nederland, Houten, The Netherlands
J Nerv Ment Dis 197:35-40. 2009
Stability and treatment outcome of distinct classes of mania
Inge van Rossum
Medical Department, Eli Lilly Nederland, Grootslag 1 5, Houten, The Netherlands
Eur Psychiatry 23:360-7. 2008
Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic setting
Inge van Rossum
Eli Lilly Nederland, Medical Department, Houten, The Netherlands
BMC Psychiatry 9:16. 2009

Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis
Inge van Rossum
Medical Department, Eli Lilly Nederland, Houten, The Netherlands
J Nerv Ment Dis 197:35-40. 2009
..An independent impact of cannabis use on psychopathologic outcomes in patients with bipolar disorder was apparent, whereas the impact on social outcomes was modest...
Stability and treatment outcome of distinct classes of mania
Inge van Rossum
Medical Department, Eli Lilly Nederland, Grootslag 1 5, Houten, The Netherlands
Eur Psychiatry 23:360-7. 2008
..Differential treatment course and outcome after 12 weeks of treatment were examined for three distinct classes of patients with acute mania in bipolar disorder...
Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic setting
Inge van Rossum
Eli Lilly Nederland, Medical Department, Houten, The Netherlands
BMC Psychiatry 9:16. 2009
..An indirect approach to examine this issue was developed, focusing on associations between dopamine proxy measures observed in BD (dopamine-related clinical traits using tardive movement syndromes as dopamine proxy measure of reference)...